
Dave had his most recent Rituxan infusion yesterday. It was the first time we had a chance to meet with his new Hematology Oncologist, Dr. L. (Dave's previous doctor moved to Seattle in July.) We were pretty impressed with him - the new guy is very young, very personable, but best of all he communicates easily and openly, with specific facts.
I had given up hope of ever learning Dave's FISH results (a test of the genetic changes in the cancer cell.) Dr. L told us, before I even had a chance to ask, that Dave has the 13q deletion, which is very good news (it's a less aggressive form of CLL.)
Dr. L plans to continue Dave's Rituxan treatments through the end of this year. He's attending a Hematology/Oncology conference in December and he will meet with us after that to decide on Dave's treatment for the coming year.